Pharmaceutical Product Supply – Drospirenone 4mg Tablets

The contract involves the supply of 1,485 units of Drospirenone 4mg tablets, all of which must comply with the specific packaging, labeling, and expiration date standards mandated by the Department of Veterans Affairs. This requirement ensures alignment with VA’s internal protocols for pharmaceutical distribution and patient safety. The solicitation is classified as a subcontract under a Total Small Business Set-Aside, as defined by the Small Business Administration and the Federal Acquisition Regulation, limiting eligibility exclusively to small businesses. The NAICS code 325412 identifies the industry as Pharmaceutical and Medicinal Chemical Manufacturing, reflecting the nature of the product being procured. The opportunity was posted on April 24, 2026, with a response deadline of May 1, 2026, at 10:00 PM Eastern Time, offering a limited window for submission. Performance of the contract is expected to be fulfilled from Tucson, though no further geographic specifics are provided. The issuing agency is the National Cmop Office under the Department of Veterans Affairs, indicating the product is designated for use within the VA healthcare system.